S&P 500
7,443.80
+1.17%
Dow Jones
52,303.60
+0.69%
Nasdaq 100
29,755.10
+2.31%
Russell 2000
2,999.95
-0.17%
FTSE 100
10,531.80
+0.25%
Nikkei 225
70,677.30
+1.41%
Stock Market Live June 29, 2026: S&P 500 (SPY) Soaring in Holiday-Shortened Week
So-Young International

So-Young International (SY) Q4 2025 Earnings

Reported Mar 25, 2026 at 6:05 AM ET · SEC Source

Q4 25 EPS

$-0.15

BEAT +77.99%

Est. $-0.68

Q4 25 Revenue

$65.9M

MISS 85.12%

Est. $442.6M

vs S&P Since Q4 25

-62.3%

TRAILING MARKET

SY -49.7% vs S&P +12.6%

Full Year 2025 Results

FY 25 EPS

$-0.34

BEAT +74.73%

Est. $-1.35

FY 25 Revenue

$217.8M

MISS 85.61%

Est. $1.51B

Market Reaction

Did SY Beat Earnings? Q4 2025 Results

So-Young International Inc. Delivered a sharp revenue miss in Q4 2025, with total revenues of $65.88 million falling 85.41% below the consensus estimate of $451.47 million and declining 82.2% year-over-year, a result that will draw scrutiny despite t… Read more So-Young International Inc. Delivered a sharp revenue miss in Q4 2025, with total revenues of $65.88 million falling 85.41% below the consensus estimate of $451.47 million and declining 82.2% year-over-year, a result that will draw scrutiny despite the company's ongoing transformation toward an offline aesthetic treatment network. The headline shortfall was amplified by the continued contraction of So-Young's legacy digital platform, where information, reservation, and medical product revenue streams kept declining even as the branded aesthetic center business scaled aggressively. The company posted an EPS loss of $0.15 for the quarter, while on a non-GAAP basis the net loss widened to $93.42 million as capital was heavily deployed into center build-outs across 15 major Chinese cities. Analysts had flagged expectations for a meaningful loss ahead of the print. Looking forward, management guided Q1 2026 aesthetic treatment services revenue of $38.30 million to $39.80 million, representing 171% to 181% growth, underscoring confidence that the offline expansion strategy will eventually reshape the company's revenue profile.

Key Takeaways

  • • Rapid expansion of branded aesthetic centers driving 205.3% growth in aesthetic treatment services
  • • Verified treatment visits grew to over 125,000 from approximately 45,000 YoY
  • • Active users exceeded 171,000 compared to approximately 52,700 a year ago
  • • Core member growth of over 14,500 in Q4, 39% sequential increase
  • • Core member revenue contribution and quarterly repurchase rate both exceeded 80%
  • • 25 of 49 aesthetic centers achieved center-level profitability in Q4
  • • 39 of 49 centers generated positive quarterly operating cash flow
24/7 Wall St

SY YoY Financials

Q4 2025 vs Q4 2024, source: SEC Filings

24/7 Wall St

SY Revenue by Segment

With YoY comparisons, source: SEC Filings

Q4 25 Q1 26

“In the fourth quarter, our aesthetic center business maintained its strong momentum, solidifying its role as a core growth engine for the Group. We have retained our position as China's leading light medical aesthetics chain by scale, which serves as a clear validation of our business model's strength and sustainability. Looking ahead, we will pursue steady store expansion while prioritizing operational excellence and industry-leading standards. Through strategic alliances with upstream manufacturers and a commitment to genuine product traceability, we are building competitive advantages rooted in both unit economics and trust. We are confident that this disciplined approach will drive sustainable value for our shareholders.”

— Xing Jin, Q4 2025 Earnings Press Release

Back to SY Stock Page